Questa Capital

Questa Capital is a healthcare venture growth equity firm based in Washington, D.C., established in 2016. The firm focuses on early-stage investments in healthcare and biotech companies across North America, with an emphasis on disruptive business models that enhance the quality and efficiency of care. By partnering with strong management teams, Questa aims to help build innovative market leaders in various sectors, including big data, software as a service, artificial intelligence, and technology. Their mission is to generate exceptional returns for both investors and management teams through strategic investments in breakout growth companies.

Eric Thakor

Vice President

23 past transactions

Aerin Medical

Private Equity Round in 2022
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion. The company's products, VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, leverage its proprietary temperature-controlled technology, which allows ENT physicians to improve patients’ symptoms with technologies that are appealing alternatives to invasive surgery.

Proximie

Series C in 2022
Proximie is a health technology platform that enables surgeons to virtually attend operating theaters to visually guide complex surgeries. Proximie combines human expertise with the power of augmented reality, artificial intelligence, and machine learning to allow a surgeon to remotely watch an operation and use their hands to demonstrate things to the surgeon conducting the operation, who sees the remote surgeon on a screen. This platform aims to democratize access to the most up-to-date and skilled knowledge on surgery practice, by helping surgeons advise each other from different parts of the world. The company was founded by Nadine Hachach-Haram in 2016 and is headquartered in London, England.

Socially Determined

Series B in 2022
Socially Determined is the social risk analytics company for organizations committed to addressing the Social Determinants of Health (SDOH). Its flagship platform SocialScape® quantifies social risk factors and analyzes the impact of these factors on health and business metrics, and its team of social risk experts provides advisory services to translate these insights into actionable solutions with measurable benefits.

Bicycle Health

Series B in 2022
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become an addiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients. Ankit Gupta established it in San Francisco, California in 2017.

Avive

Series A in 2022
Avive Solutions, Inc. specializes in developing advanced Automated External Defibrillators (AEDs) and accompanying software solutions aimed at improving response to Sudden Cardiac Arrest (SCA). Founded in 2017 and headquartered in San Francisco, California, the company focuses on removing barriers that hinder effective SCA responses. Avive's AED is designed to be user-friendly, portable, and affordable, enabling individuals to respond confidently in emergency situations. Additionally, the device features a connected platform that facilitates the transmission of crucial incident data to emergency services and healthcare professionals, thereby enhancing the overall effectiveness of SCA interventions and increasing survival rates.

Vynca

Series C in 2022
VyncaCare provides palliative care, advanced care planning, and enhanced care management services.

Cortica

Series C in 2021
Cortica Inc. is a healthcare company focused on providing neurological therapies for children with autism and other neurodevelopmental challenges. Established in 2014 and based in San Diego, California, Cortica offers personalized treatment programs that are tailored to each child's neurobiology and developmental profile. The company employs a multidisciplinary approach, utilizing insights from emerging neuroscience to deliver comprehensive care through in-home, in-clinic, and telehealth services. Its offerings include evidence-based therapies such as applied behavior analysis (ABA), speech therapy, and occupational therapy, all aimed at fostering independent living, educational opportunities, and social relationships for children with developmental differences. Cortica operates multiple centers in California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

Bicycle Health

Series A in 2021
Bicycle Health is a virtual addiction medicine clinic that helps treat opioid dependence or use disorder. Addiction medicine specialists on the Bicycle Health platform will treat patients and works with the patient's insurance to get reimbursed for their services. The telemedicine-based company uses an interesting model to become an addiction medicine resource that physicians leverage for their patients while maintaining and strengthening their relationship with their patients. Ankit Gupta established it in San Francisco, California in 2017.

Claritas Rx

Private Equity Round in 2021
Claritas Rx is a data integration and analytics company for pharmaceutical manufacturers. It leverages a proprietary technology platform and deep manufacturer expertise to automate and integrate channel, commercial, and clinical data and help biopharmaceutical companies generate actionable business insights.

Eko Health

Series C in 2020
Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

ControlRad

Series C in 2020
ControlRad Systems, Inc. is a medical device company based in Radnor, Pennsylvania, focused on developing systems that minimize radiation exposure during fluoroscopic procedures. Established in 2011, the company offers innovative solutions for both mobile and fixed C-arm systems. Its manually controlled region of interest (ROI) product enables physicians to customize the radiation field by identifying specific areas of focus manually. In contrast, the automatically controlled ROI product uses eye-tracking technology, allowing physicians to direct radiation to the area of interest based on their gaze, thereby optimizing radiation dosage while protecting peripheral regions. ControlRad aims to significantly reduce the lifetime risk of radiation exposure for patients and healthcare professionals without compromising image quality or workflow efficiency.

Aerin Medical

Venture Round in 2020
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion. The company's products, VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, leverage its proprietary temperature-controlled technology, which allows ENT physicians to improve patients’ symptoms with technologies that are appealing alternatives to invasive surgery.

DispatchHealth

Series C in 2020
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services based in Denver, Colorado. Founded in 2013, the company offers a wide range of services including acute injury and illness evaluations, laceration repair, splinting of injured extremities, treatment for nosebleeds, placement of Foley and G-tubes, medication administration, laboratory testing, and coordination with primary care physicians and home health agencies. By delivering care in the comfort of patients' homes, DispatchHealth aims to reduce unnecessary emergency room visits and hospitalizations, improve clinical outcomes, and lower overall healthcare costs. The organization focuses on creating an integrated and convenient healthcare solution that enhances the capabilities of patients' care teams and ensures high-quality care.

Eximis Surgical

Series A in 2020
Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

Cortica

Venture Round in 2020
Cortica Inc. is a healthcare company focused on providing neurological therapies for children with autism and other neurodevelopmental challenges. Established in 2014 and based in San Diego, California, Cortica offers personalized treatment programs that are tailored to each child's neurobiology and developmental profile. The company employs a multidisciplinary approach, utilizing insights from emerging neuroscience to deliver comprehensive care through in-home, in-clinic, and telehealth services. Its offerings include evidence-based therapies such as applied behavior analysis (ABA), speech therapy, and occupational therapy, all aimed at fostering independent living, educational opportunities, and social relationships for children with developmental differences. Cortica operates multiple centers in California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

ControlRad

Series B in 2019
ControlRad Systems, Inc. is a medical device company based in Radnor, Pennsylvania, focused on developing systems that minimize radiation exposure during fluoroscopic procedures. Established in 2011, the company offers innovative solutions for both mobile and fixed C-arm systems. Its manually controlled region of interest (ROI) product enables physicians to customize the radiation field by identifying specific areas of focus manually. In contrast, the automatically controlled ROI product uses eye-tracking technology, allowing physicians to direct radiation to the area of interest based on their gaze, thereby optimizing radiation dosage while protecting peripheral regions. ControlRad aims to significantly reduce the lifetime risk of radiation exposure for patients and healthcare professionals without compromising image quality or workflow efficiency.

DispatchHealth

Series B in 2019
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services based in Denver, Colorado. Founded in 2013, the company offers a wide range of services including acute injury and illness evaluations, laceration repair, splinting of injured extremities, treatment for nosebleeds, placement of Foley and G-tubes, medication administration, laboratory testing, and coordination with primary care physicians and home health agencies. By delivering care in the comfort of patients' homes, DispatchHealth aims to reduce unnecessary emergency room visits and hospitalizations, improve clinical outcomes, and lower overall healthcare costs. The organization focuses on creating an integrated and convenient healthcare solution that enhances the capabilities of patients' care teams and ensures high-quality care.

Barricaid

Series E in 2019
Barricaid develops a bone-anchored implant that reduces the incidence of reherniation and reoperation in patients with large annular defects. It is designed to prevent reherniation by physically blocking the annulus at the post-surgery defect. The anchor component is comprised of titanium alloy that is placed into either the caudal or cranial-adjacent vertebral body to secure the device in position.

Cortica

Venture Round in 2018
Cortica Inc. is a healthcare company focused on providing neurological therapies for children with autism and other neurodevelopmental challenges. Established in 2014 and based in San Diego, California, Cortica offers personalized treatment programs that are tailored to each child's neurobiology and developmental profile. The company employs a multidisciplinary approach, utilizing insights from emerging neuroscience to deliver comprehensive care through in-home, in-clinic, and telehealth services. Its offerings include evidence-based therapies such as applied behavior analysis (ABA), speech therapy, and occupational therapy, all aimed at fostering independent living, educational opportunities, and social relationships for children with developmental differences. Cortica operates multiple centers in California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

Eximis Surgical

Venture Round in 2018
Eximis Surgical, founded in 2014 and headquartered in Louisville, Colorado, specializes in developing innovative technology for laparoscopic surgery. The company has created a specimen removal device that enables surgeons to efficiently extract large specimens through small incisions. This device utilizes radio frequency (RF) energized cutting wires, which are temporarily held in a containment bag, allowing for quick and safe specimen removal. By integrating seamlessly into existing physician protocols, Eximis Surgical's technology significantly reduces the time required for specimen extraction, minimizes patient discomfort, and ensures safe surgical outcomes. Additionally, the device separates specimens into narrow strips, facilitating the creation of clean tissue segments for accurate pathology identification, thereby enhancing the overall effectiveness of minimally invasive surgery.

DispatchHealth

Venture Round in 2017
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services based in Denver, Colorado. Founded in 2013, the company offers a wide range of services including acute injury and illness evaluations, laceration repair, splinting of injured extremities, treatment for nosebleeds, placement of Foley and G-tubes, medication administration, laboratory testing, and coordination with primary care physicians and home health agencies. By delivering care in the comfort of patients' homes, DispatchHealth aims to reduce unnecessary emergency room visits and hospitalizations, improve clinical outcomes, and lower overall healthcare costs. The organization focuses on creating an integrated and convenient healthcare solution that enhances the capabilities of patients' care teams and ensures high-quality care.

Medrio

Venture Round in 2017
Medrio, Inc. is a medical software company that specializes in Web-based electronic data capture (EDC) solutions tailored for clinical research applications. Established in 2005 and headquartered in San Francisco, California, with additional offices in Pune, India, and Paris, France, Medrio's offerings support a range of clinical research activities, including phase I-IV trials, outcomes research, registries, and retrospective chart reviews. The company's platform enables users to design, configure, and manage clinical research projects efficiently through a user-friendly Web interface. Medrio's clientele includes pharmaceutical and biotechnology companies, contract research organizations (CROs), academic institutions, and other clinical research entities, benefiting from its advanced EDC and eClinical tools designed to streamline data management while reducing costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.